Related Experiment Video
Updated: Jun 1, 2026

09:29
Electrospinning Growth Factor Releasing Microspheres into Fibrous Scaffolds
Published on: August 16, 2014
Stromal-derived factor-1 alpha-loaded PLGA microspheres for stem cell recruitment
1Department of Biomedical Engineering, University of Minnesota, 7-105 Hasselmo Hall, 312 Church Street S. E., Minneapolis, MN 55455, USA.
Pharmaceutical Research
|May 27, 2011
Summary
Biodegradable microspheres effectively deliver stromal-derived factor-1 alpha (SDF-1α) for over 50 days, stimulating stem cell migration. This sustained release of SDF-1α holds promise for regenerative medicine applications.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Drug Delivery Systems
Background:
- Stromal-derived factor-1 alpha (SDF-1α) is a key chemokine for recruiting endogenous stem cells to injury sites.
- Sustained delivery of SDF-1α is crucial for effective stem cell recruitment in therapeutic applications.
Purpose of the Study:
- To develop and characterize biodegradable poly(lactide-co-glycolide) (PLGA) microspheres for sustained SDF-1α delivery.
- To evaluate the in vitro release kinetics and bioactivity of SDF-1α from PLGA microspheres.
Main Methods:
- SDF-1α was encapsulated into PLGA microspheres using a double-emulsion solvent extraction/evaporation technique.
- Microsphere formulation parameters were optimized to control encapsulation efficiency and release profiles.
- The bioactivity of released SDF-1α was assessed by measuring mesenchymal stem cell (MSC) migration.
Main Results:
- Optimized PLGA microspheres achieved high encapsulation efficiency (>64%) for SDF-1α.
- Sustained release of bioactive SDF-1α was observed for over 50 days.
- Released SDF-1α significantly stimulated MSC migration throughout the release period.
Conclusions:
- Key formulation variables were identified for successful SDF-1α encapsulation and sustained release from PLGA microspheres.
- SDF-1α-loaded PLGA microspheres represent a promising injectable system for sustained chemokine delivery.
- This approach facilitates the recruitment of endogenous stem cells to injury sites for therapeutic purposes.

